Related content

An Altered Histaminergic Innervation of the Substantia Nigra in Parkinson's Disease

By Anichtchik O.V.   Rinne J.O.   Kalimo H.   Panula P.  

Experimental Neurology, Vol. 163, Iss. 1, 2000-05 ,pp. : 20-30

Elsevier

Access to resources Recommend Favorite

Morphometry of the human substantia nigra in ageing and Parkinson’s disease

By Rudow Gay   O’Brien Richard   Savonenko Alena   Resnick Susan   Zonderman Alan   Pletnikova Olga   Marsh Laura   Dawson Ted   Crain Barbara   West Mark   Troncoso Juan  

Acta Neuropathologica, Vol. 115, Iss. 4, 2008-04 ,pp. : 461-470

Springer Publishing Company

Access to resources Recommend Favorite

Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra

By Howells D.W.   Porritt M.J.   Wong J.Y.F.   Batchelor P.E.   Kalnins R.   Hughes A.J.   Donnan G.A.  

Experimental Neurology, Vol. 166, Iss. 1, 2000-11 ,pp. : 127-135

Elsevier

Access to resources Recommend Favorite

α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease

By Halliday Glenda M.   Ophof Anita   Broe Melissa   Jensen Poul H.   Kettle Emma   Fedorow Heidi   Cartwright Michael I.   Griffiths Francine M.   Shepherd Claire E.   Double Kay L.  

Brain, Vol. 128, Iss. 11, 2005-11 ,pp. : 2654-2664

Oxford University Press

Access to resources Recommend Favorite

Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a Rhesus monkey model of Parkinson's disease

By Li Hongjun   He Zhanlong   Su Ting   Ma Yanbing   Lu Shuaiyao   Dai Changbai   Sun Maosheng  

Neurological Research, Vol. 25, Iss. 3, 2003-04 ,pp. : 263-267

Maney Publishing

Access to resources Recommend Favorite